Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2005
09/29/2005US20050214392 Treatments for immune systems disorders
09/29/2005US20050214378 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
09/29/2005US20050214360 Diclofenac sodium oral pharmaceutical
09/29/2005US20050214334 Composition for topical substance delivery
09/29/2005US20050214314 Human cytokine receptor
09/29/2005US20050214295 Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shock
09/29/2005US20050214291 Treatment method
09/29/2005US20050214272 Antiinflammatory agents for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome
09/29/2005US20050214247 Glycodendrimers having biological activity
09/29/2005CA2562388A1 Emulsion-stabilized preparation
09/29/2005CA2560953A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005CA2560279A1 Use of a 5-ht3 receptor antagonist for the manufacture of a medicament for the treatment of non-digestive tract derived abdominal disorders associated with pain
09/29/2005CA2560247A1 Thrombin derivative and pharmaceutical composition containing the same
09/29/2005CA2559629A1 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
09/29/2005CA2559545A1 Tetra-cyclic carboline derivatives for inhibiting angiogenesis
09/29/2005CA2558126A1 The treatment of inflammatory disorders and pain using beta-aminoalcohols
09/29/2005CA2558096A1 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition
09/29/2005CA2558023A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
09/29/2005CA2557054A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/29/2005CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1580192A2 16-Hydroxyestratrienes as selective estrogens
09/28/2005EP1580188A1 Aryl ureas as kinase inhibitors
09/28/2005EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof
09/28/2005EP1579868A2 Use of IL-11 for treating various diseases
09/28/2005EP1578988A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
09/28/2005EP1578917A2 Multimeric proteins and methods of making and using same
09/28/2005EP1578914A2 Human ion channels
09/28/2005EP1578902A2 Neurotransmission-associated proteins
09/28/2005EP1578899A2 Secreted proteins
09/28/2005EP1578787A1 Novel chi-conotoxin peptides (-ii)
09/28/2005EP1578771A2 Remodeling and glycoconjugation of peptides
09/28/2005EP1578758A2 Purine nucleosides
09/28/2005EP1578741A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/28/2005EP1578736A1 Mek inhibiting oxa- and thia-diazol-2-yl-phenylamine derivatives
09/28/2005EP1578721A2 Processes for the preparation of substituted isoxazoles and 2-isoxazolines
09/28/2005EP1578425A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
09/28/2005EP1578416A1 Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles
09/28/2005EP1578351A2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
09/28/2005EP1578252A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
09/28/2005EP1463731B1 Dibenzodiazepine derivates, their preparation and use
09/28/2005EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes
09/28/2005EP1361880B1 6-substituted pyrido-pyrimidines
09/28/2005EP1267905B1 Composition for the treatment of heart failure
09/28/2005EP1243583B1 Heterocyclic compounds having sulfonamide groups
09/28/2005EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
09/28/2005EP1210348B1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
09/28/2005EP1178781B1 Multilayer pharmaceutical product for release in the colon
09/28/2005EP1135486B1 RECOMBINANT SOLUBLE Fc RECEPTORS
09/28/2005EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
09/28/2005EP0832071B1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
09/28/2005CN1675344A Oil or fat composition
09/28/2005CN1675229A Sulfur-containing phospholipid derivatives
09/28/2005CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines
09/28/2005CN1675208A Novel fused imidazole derivative
09/28/2005CN1675207A 6-alkoxy-pyrido-pyrimidines as p-38 MAP kinase inhibitors
09/28/2005CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same
09/28/2005CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/28/2005CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675184A Caspase inhibitors and uses thereof
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/28/2005CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
09/28/2005CN1674931A T cell receptor CDR3 sequences and methods for detection
09/28/2005CN1674924A Use of fermented wheat germ extract as anti-inflammatory agent
09/28/2005CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis
09/28/2005CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
09/28/2005CN1674907A Use of reboxetine for the treatment of hot flashes
09/28/2005CN1674899A Use of IkappaB-kinase inhibitors in pain therapy
09/28/2005CN1674892A Hetero biaryl derivatives as matrix metalloproteinase inhibitors
09/28/2005CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
09/28/2005CN1674875A Anti-microbial compositions and methods of using same
09/28/2005CN1674870A Liposomes containing biologically active compounds
09/28/2005CN1674868A Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent
09/28/2005CN1674864A Topical formulation for prevention and treatment of acne
09/28/2005CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
09/28/2005CN1673363A Pallas pit viper active hepatoenzyme
09/28/2005CN1672725A Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process
09/28/2005CN1672694A Tuireling for allaying fever and its prepn
09/28/2005CN1672682A Prepn containing fibrauretine microcapsule and its prepn process
09/28/2005CN1220717C Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220520C Inhibition of 2, 3-dihydrogen-indone to 26S and 20S prolease
09/28/2005CN1220518C Chinese medicinal composition for anti-cancer and analgesia, its preparation method and its application
09/28/2005CN1220513C Chinese patent medicine for stopping blood, analgesia, removing blood stasis and engender new and its preparation method
09/27/2005US6949664 Acyclic unsaturated alcohols such as lipoxins, prepared by hydrogenation in the presence of lindlar's catalysts, for use as antiinflammmatory or antiproliferative agents
09/27/2005US6949651 A thiazolo(5,4-b)pyridine-5,7-dione derivatives for treating arthritis, inflammation, cancer
09/27/2005US6949648 Condensed pyrazole derivatives, process for producing the same and use thereof
09/27/2005US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases
09/27/2005US6949643 Thiazolopytimidines and their use as modulators of chemokine receptor activity
09/27/2005US6949585 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents
09/27/2005US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
09/27/2005US6949566 For use as metalloproteinase inhibitors
09/27/2005US6949565 Protein kinase inhibitors
09/27/2005US6949560 Imidazo-substituted compounds as p38 kinase inhibitors
09/27/2005US6949554 Calcium channel blockers comprising two benzhydril moieties
09/27/2005US6949553 Aliphatic compounds, their synthesis method, and utilization of the same
09/27/2005US6949546 N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
1 ... 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 ... 1272